Back
Myriad Genetics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
32
MYGN
Myriad Genetics, Inc.
Last Price:
$7.34
Seasonality Move:
17.86%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiMyriad Genetics, Inc. Stock Forecast
-
Over the next 52 weeks, Myriad Genetics, Inc. has on average historically risen by 21.8% based on the past 30 years of stock performance.
-
Myriad Genetics, Inc. has risen higher in 13 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 43.33%
-
Is Myriad Genetics, Inc. Stock Undervalued?The current Myriad Genetics, Inc. [MYGN] share price is $7.33. The Score for MYGN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
MYGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Myriad Genetics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Myriad Genetics, Inc. has on average historically risen by 21.8% based on the past 30 years of stock performance.
Myriad Genetics, Inc. Stock Rating
Sell
32
Myriad Genetics, Inc. (MYGN)
is a Sell
Is Myriad Genetics, Inc. overpriced?
-
Myriad Genetics, Inc. has risen higher in 13 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 43.33%
Myriad Genetics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
myriad.com
52-Week Data
52-Week High:
16.63
52-Week Low:
3.76
Prediction Charts
Market Cap:
683.3M
Price in USD:
7.33
Volume:
695.1K
Beta:
1.11
Technical Analysis
SMA50:
7.43
SMA100:
6.67
SMA200:
6.92
52-Wk Change:
-55.84%
Stock Predictions
-
Is Myriad Genetics, Inc. stock public?Yes, Myriad Genetics, Inc. is a publicly traded company.
-
What is the Myriad Genetics, Inc. stock quote today?The Myriad Genetics, Inc. stock price is 7.33 USD today.
-
How to buy Myriad Genetics, Inc. stock online?You can buy Myriad Genetics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 6.25 | 6.71 | 6.83 | 6.25 |
| Nov-17 | 6.60 | 6.66 | 6.89 | 6.49 |
| Nov-18 | 6.61 | 6.63 | 6.87 | 6.61 |
| Nov-19 | 6.60 | 6.44 | 6.89 | 6.43 |
| Nov-20 | 6.59 | 6.90 | 7.24 | 6.55 |
| Nov-21 | 6.91 | 7.38 | 7.49 | 6.82 |
| Nov-24 | 7.38 | 7.73 | 7.79 | 7.32 |
| Nov-25 | 7.83 | 7.91 | 8.09 | 7.71 |
| Nov-26 | 7.89 | 7.60 | 7.89 | 7.57 |
| Nov-28 | 7.63 | 7.63 | 7.72 | 7.51 |
| Dec-1 | 7.54 | 7.06 | 7.54 | 7.01 |
| Dec-2 | 7.06 | 7.02 | 7.15 | 6.93 |
| Dec-3 | 7.06 | 7.33 | 7.35 | 7.02 |
| Dec-4 | 7.31 | 7.33 | 7.38 | 7.15 |
Myriad Genetics, Inc. Earnings
Myriad Genetics, Inc. Earnings Report: Per Share Myriad Genetics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Myriad Genetics, Inc. Forecast Revenue Growth
Myriad Genetics, Inc. Stock Analysis: Historical quarterly revenues per share for Myriad Genetics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and an increase next year of $0.06 per share.
* Myriad Genetics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.